We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information on a number of schemes designed to avoid Income Tax and National Insurance contributions by using capital advances, joint and mutual share ownership agreements.
This series brings together all documents relating to Joint Doctrine Note (JDN)
Allied Joint Publication-01 provides capstone doctrine for Allied joint operations.
To provide the necessary Firm Base support to service personnel, civilians and their families serving with NATO and the European Union in Europe and Turkey to deliver success on operations.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Allied Joint Publication-3.28 sets out the principles and general guidance necessary to plan and conduct military support to stabilization.
Guidance for the veterinary pharmaceutical industry on the production and submission of the Summary of Product Characteristics (SPCs) and product literature mock-ups.
To enable the delivery by air, of personnel, machines and materiel through development trials, and training to enhance defence capability.
You can ask to have your joint annuity paid without tax taken off by using form R86.
This series brings together all documents relating to Joint Doctrine Publication (JDP)
This guidance covers ‘grandfathering’ and managing the lifecycle changes of medicinal products.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
Communiqués from the Joint Ministerial Committee (EU Negotiations)
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
This joint declaration between the UK and the British Overseas Territories establishes a vision for modern, collaborative partnerships fit for the 21st century.
Explainer for the pharmaceutical industry on the ongoing implementation of the Veterinary Medicines Regulation relating to applications and authorisations for veterinary medicines.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.